Yue Hou

7PUBLICATIONS
13CO-AUTHORS
Molecular targetsTraditional Chinese medicine and treatmentsBiomolecular modelling and designAutoimmunityInfectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 12, 2025
Author Correction: CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer.

Chunge Zhong, Wen-Jie Jiang, Yingjia Yao

|Jul 08, 2024
Tamarixetin ameliorates cerebral ischemia-reperfusion injury via suppressing nicotinamide adenine dinucleotide phosphate oxidase 2/nucleotide-binding oligomerization domain like receptor family pyrin domain-containing 3 inflammasome activation.

Yanqiu Yang, Feng Wang, Mingxia Fang

|Jul 01, 2024
CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer.

Chunge Zhong, Wen-Jie Jiang, Yingjia Yao

|Jan 11, 2024
De Novo Generation and Identification of Novel Compounds with Drug Efficacy Based on Machine Learning.

Dakuo He, Qing Liu, Yan Mi

|May 20, 2023
Isoamericanin A improves lipopolysaccharide-induced memory impairment in mice through suppression of the nicotinamide adenine dinucleotide phosphateoxidase-dependent nuclear factor kappa B signaling pathway.

Yanqiu Yang, Ru Chen, Yue Che

|Mar 29, 2021
Regulation of Superoxide by BAP31 through Its Effect on p22<sup>phox</sup> and Keap1/Nrf2/HO-1 Signaling Pathway in Microglia.

Xia Liu, Qing Yuan, Guo-Xun Li

Pageof 2

Frequent Collaborators

2 joint publications

Chunge Zhong

2 joint publications

Wen-Jie Jiang

2 joint publications

Zexu Li

2 joint publications

Zihan Li